Synthesis and SAR of N-chlorophenyl substituted Piperazinylethyl-aminomethylpyrazoles as 5-HT3A inhibitors

Bulletin of the Korean Chemical Society

Volumn 30, Issue 11, 2009, Pages 2707-2712

  Lee, Byung Hwan ^a   Choi, In Sung ^b   Rhim, Hyewhon ^b   Choi, Kyung Il ^b   Nah, Seung Yeol ^a   Nam, Ghilsoo ^b  

^a Konkuk University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

5 HT3 receptor; 5 HT3A receptor channel activity; Chlorophenyl substituted piperazinylethylaminomethylpyrazoles; Novel 5 HT3 receptor channel current blockers

Indexed keywords

ANTI-CANCER AGENTS; HIGH POTENCY; LIGAND-GATED ION CHANNELS; LOW POTENCY; PYRAZOLE DERIVATIVES; RECEPTOR ANTAGONISTS; RECEPTOR CHANNELS;

CHLORINE COMPOUNDS;

EID: 75849141266     PISSN: 02532964     EISSN: 12295949     Source Type: Journal    
DOI: 10.5012/bkcs.2009.30.11.2707     Document Type: Article

References (16)

1. Hoyer, D.; Clarke, D. E.; Fozard, J. R.; Hartig, P. R.; Martin, G. R.; Mylecharane, E. J.; Saxena, P. R.; Humphrey, P. P. Pharmacol. Rev. 1994, 46, 157-203.
2. Dekash, V.; Surprenant, A.; North, R. A. Nature 1989, 339, 706709.
3. Maricq, A.V.; Peterson, A. S.; Brake, A. J.; Myers, R. M.; Julius, D. Science 1991, 254, 432-437.
4. Jackson, M. B.; Yakel, J. L. Annu. Rev. Physiol. 1995, 57, 447-468.
5. Lummis, S. C.; Martin, J. L. Mol. Pharmacol. 1992, 41, 18-23.
6. Kranzler, H. R.; Pierucci-Lagha, A.; Feinn, R.; Hernandez-Avila, C. Clin. Exp. Res. 2003, 27, 1150-1155.
7. Gaster, L. M.; King, F. D. Med. Res. Rev. 1997, 17, 163-214.
8. Silverstone, P. H.; Greenshaw, A. J. Exp. Opin. Ther. Patents 1996, 6, 471-481.
9. ecrubier, Y.; Peuch, A. J.; Azcona, A.; Bailey, P. E.; Lataste, X. Psycopharmacology 1993, 112, 129-133.
10. Ait-Daoud, N.; Jonson, B. A. Addict. Dissord. Treat. 2002, 1, 75-80.
11. Hodge, C. W.; Kelley, S. P.; Bratt, A. M.; Iller, K.; Schroeder, J. P.; Besheer, J. Neuropsychopharmacology 2004, 29, 1807-1813.
12. Bell, R.; Gilmore, P. E. J. Psycopharmacol. (Oxford) 2003, 17(3), suppl. A30.
13. Preston, G. C. Int. Acad. Biomed. Drug. Res. 1994, 7, 89-93.
14. Fiebich, B. L.; Akundi, R. S.; Lieb, K.; Candelario-Jalil, E.; Gmeiner, D.; Haus, U.; Muller, W.; Stratz, T.; Munoz, E. J. Rheumatol. 2004, 33, 28-32.
15. Nam, G.; Choi, K.; Koh, H. Y.; Pae, A. N.; Rhim, H.; Choi, I. S. KP 10-0654328.
16. Lee, B. H.; Lee, J. H.; Lee, S. M.; Jeong, S. M.; Yoon, I. S.; Lee, J. H.; Choi, S. H.; Pyo, M. K.; Rhim, H.; Kim, H. C.; Jang, C. G.; Lee, B. C.; Park, C. S.; Nah, S. Y. Neuropharmacology 2007, 52, 1139-1150.